Lion, Ingenuity, Gene Network Sciences, Cancer Biomarker Database, Genedata, Compugen | GenomeWeb

Lion's Q4 Revenues Slide; Sale of Bioinformatics Biz Expected by End of Summer

Lion Bioscience posted a nearly 70-percent decline in quarterly revenues for its fourth fiscal quarter ended March 31, according to full-year results that the company released as BioInform went to press last week.

According to these results, receipts fell to around €1.2 million ($1.5 million) for the quarter, from €3.9 million in the year-ago period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.